All In Biotech

Drug Trial Radar · NCT07429266

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

A Phase 3 Randomized, Double-blind, Placebo-controlled Global Study of Sapablursen in Polycythemia Vera

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

May 25, 2026

Primary completion

Sep 2028

Study completion Jan 2031

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
Collaborators
Deciphera Pharmaceuticals, LLC
First posted
Feb 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of care (SOC) for Polycythemia Vera (PV) therapy. The study will be conducted in three sequential parts (Part 1a blinded treatment, Part 1b open-label treatment, \& Part 2 long-term extension). Participants may receive treatment for up to 156 weeks.

Conditions

  • Polycythemia Vera

Interventions

  • SapablursenDrug

    Administered subcutaneously (SC)

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Absence of Phlebotomy EligibilityTime frame: Week 20 through Week 32

Locations

38 sites in 9 countries. Site status is shown where the registry gives one.

  • UC Irvine Health - Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • Regis Clinical Research LLC.

    Miami, Florida · Recruiting

  • Florida Clinical Trials Group

    Plantation, Florida · Recruiting

  • Florida Clinical Trials Group

    Tamarac, Florida · Recruiting

  • Central Georgia Cancer Care

    Macon, Georgia · Recruiting

  • The Center for Cancer & Blood Disorders

    Bethesda, Maryland · Recruiting

  • The Cancer and Hematology Centers

    Grand Rapids, Michigan · Recruiting

  • Montefiore Medical Center

    The Bronx, New York · Recruiting

  • Gabrail Cancer Center Research

    Canton, Ohio · Recruiting

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University

    Columbus, Ohio · Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania · Recruiting

  • University of Texas M.D. Anderson Cancer Center

    Houston, Texas · Recruiting

  • Hematology Oncology Associates of Fredericksburg

    Fredericksburg, Virginia · Recruiting

  • Austin Health

    Heidelberg, Australia · Recruiting

  • Icon Cancer Centre Kurralta Park

    Kurralta Park, Australia · Recruiting

  • Perth Blood Institute

    West Perth, Western Australia, Australia · Recruiting

  • Medizinische Universität Graz, Klinische Abteilung für Hämatologie

    Graz, Austria · Recruiting

  • Instituto Joinvilense de Hematologia e Oncologia LTDA

    Santa Catarina, Brazil · Recruiting

  • Hospital Ophir Loyola

    Belém, Pará, Brazil · Recruiting

  • Meso Clinic Servicos Medicos Ltda

    Blumenau, Santa Catarina, Brazil · Recruiting

  • Centre Hospitalier Universitaire d'Angers

    Angers, France · Recruiting

  • Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud

    Pierre-Bénite, France · Recruiting

  • Cortex Study Center

    Budapest, Hungary · Recruiting

  • Gyor-Moson-Sopron County Petz Aladar University Teaching Hospital

    Győr, Hungary · Recruiting

  • Japanese Red Cross Nagasaki Genbaku Hospital

    Nagasaki, Japan · Recruiting

  • Osaka Metropolitan University Hospital

    Osaka, Japan · Recruiting

  • Institute of Science Tokyo Hospital

    Tokyo, Japan · Recruiting

  • Tokyo Women's Medical University Hospital

    Tokyo, Japan · Recruiting

  • Aidport Sp. z. o. o.

    Skórzewo, Poland · Recruiting

  • MICS Centrum Medyczne Torun

    Torun, Poland · Recruiting

  • Pratia Onkologia Wroclaw

    Wroclaw, Poland · Recruiting

  • Royal Devon University Healthcare NHS Foundation Trust

    Exeter, United Kingdom · Recruiting

  • Imperial College Healthcare NHS Trust

    London, United Kingdom · Recruiting

  • The New Castle upon Tyne Hospital

    Newcastle upon Tyne, United Kingdom · Recruiting

  • Royal Gwent Hospital

    Newport, United Kingdom · Recruiting

  • Nottingham University Hospitals NHS Trust

    Nottingham, United Kingdom · Recruiting

  • GensisCare

    Oxford, United Kingdom · Recruiting

  • Genesis Care Windsor

    Windsor, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.